Kyrochristou, I.; Lianos, G.D.; Kyrochristou, G.D.; Anagnostopoulos, G.; Bali, C.; Boussios, S.; Mitsis, M.; Schizas, D.; Vlachos, K.
Agnostic Biomarkers and Molecular Signatures in Colorectal Cancer—Guiding Chemotherapy and Predicting Response. Biomedicines 2025, 13, 2038.
https://doi.org/10.3390/biomedicines13082038
AMA Style
Kyrochristou I, Lianos GD, Kyrochristou GD, Anagnostopoulos G, Bali C, Boussios S, Mitsis M, Schizas D, Vlachos K.
Agnostic Biomarkers and Molecular Signatures in Colorectal Cancer—Guiding Chemotherapy and Predicting Response. Biomedicines. 2025; 13(8):2038.
https://doi.org/10.3390/biomedicines13082038
Chicago/Turabian Style
Kyrochristou, Ilektra, Georgios D. Lianos, Gerasimia D. Kyrochristou, Georgios Anagnostopoulos, Christina Bali, Stergios Boussios, Michail Mitsis, Dimitrios Schizas, and Konstantinos Vlachos.
2025. "Agnostic Biomarkers and Molecular Signatures in Colorectal Cancer—Guiding Chemotherapy and Predicting Response" Biomedicines 13, no. 8: 2038.
https://doi.org/10.3390/biomedicines13082038
APA Style
Kyrochristou, I., Lianos, G. D., Kyrochristou, G. D., Anagnostopoulos, G., Bali, C., Boussios, S., Mitsis, M., Schizas, D., & Vlachos, K.
(2025). Agnostic Biomarkers and Molecular Signatures in Colorectal Cancer—Guiding Chemotherapy and Predicting Response. Biomedicines, 13(8), 2038.
https://doi.org/10.3390/biomedicines13082038
